PubMed · 12372169
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
Enriqueta Ochoa Mangado. 2002-09-28. [Designer drugs].. https://doi.org/10.1016/s0025-7753(02)73421-0
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
In the 60 years since C H Li reported the isolation of bovine growth hormone (GH), endocrinologists have seen the widespread use of human GH for statural disorders, the measurement of plasma GH as a diagnostic test, the full development of the somatomedin hypothesis and the molecular details of the function of the GH receptor responsible for regulating somatic growth and metabolism. In diabetes, we have passed from administration of animal insulin to formulations with different release rates, insulin pumps and inhalers, insulin sensitizers and a greater understanding of insulin signalling and insulin resistance through genetically engineered murine models. What might we expect over the next few decades?
Explore the source record for details and available documents.
Explore the source record for details and available documents.